Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
My New Book is Now A Best Seller | Order Now My New Book is Now A Best Seller | Order Now

Hidden Danger in Ozempic? Sudden Blindness Risk Surfaces

  • December 16, 2024

Novo Nordisk’s diabetes drug Ozempic and its weight-loss version Wegovy, both containing semaglutide, have been linked to a rare eye condition called non-arteritic anterior ischemic optic neuropathy (NAION). Recent studies, including one published in JAMA Ophthalmology, show that diabetic patients taking semaglutide may be 4.28 times more likely to develop NAION, while overweight or obese patients face a 7.64 times higher risk compared to those using other medications. NAION reduces...